Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",21983,197,1.12 [0.76-1.65],0.579638125942959
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23204,251,1.16 [0.82-1.64],0.4015843443106122
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",22929,1768,1.10 [0.97-1.26],0.1395034030411452
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Candidiasis,23210,551,0.94 [0.74-1.19],0.5813795512379343
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,22452,4259,1.04 [0.96-1.14],0.3441010544153812
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),22390,4331,1.11 [1.02-1.21],0.0185160216404292
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,22916,1436,1.09 [0.94-1.26],0.2430804418101497
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23112,129,1.35 [0.83-2.20],0.2216458247530413
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,20372,1312,1.12 [0.96-1.31],0.1501798234718334
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,19660,1601,1.20 [1.04-1.38],0.0101061285104884
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,19149,344,1.09 [0.81-1.47],0.5832370308905379
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,15089,2769,1.02 [0.91-1.13],0.7490575643102255
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,19086,503,1.60 [1.25-2.05],0.00019604109387
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23188,1708,1.13 [0.99-1.29],0.0806980496899598
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Mycoses,23306,647,1.00 [0.80-1.24],0.975300266509608
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22413,1252,1.09 [0.93-1.28],0.2669901815490496
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23235,1449,1.09 [0.95-1.26],0.2238247399133309
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,21731,251,1.18 [0.83-1.67],0.3643770960311959
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23366,67,1.86 [0.96-3.64],0.0676274911559291
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23050,1264,1.09 [0.93-1.27],0.2708487337478414
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23064,81,0.78 [0.42-1.43],0.4190416371731429
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23299,144,1.22 [0.77-1.94],0.3948780667477198
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23277,122,1.22 [0.74-2.01],0.4390528004358878
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,21667,506,1.05 [0.82-1.34],0.7056248937088624
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,21471,310,1.30 [0.95-1.78],0.0978346870574147
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,21620,140,1.78 [1.12-2.83],0.0147070041188574
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23351,51,1.11 [0.52-2.39],0.7822314359426203
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23298,176,0.90 [0.59-1.36],0.6061536586066535
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Viral warts,23178,56,1.21 [0.58-2.53],0.6185398910070357
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23203,81,0.78 [0.42-1.45],0.4277754239087363
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign lipomatous neoplasm,23071,265,0.72 [0.51-1.01],0.0553871598874992
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23282,39,0.49 [0.20-1.21],0.1222595185770011
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23265,44,0.72 [0.32-1.66],0.4455275449602824
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,11131,85,0.80 [0.44-1.45],0.4595925975498001
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",22895,1688,0.77 [0.67-0.88],0.0001347134509701
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm of meninges,23350,64,1.23 [0.61-2.48],0.5630407518440832
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23270,78,1.32 [0.70-2.46],0.3892886468928843
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23339,119,1.13 [0.68-1.87],0.6421729203574869
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm of ovary,12165,80,0.87 [0.46-1.64],0.6706757635904945
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23326,445,0.72 [0.55-0.93],0.0133515112098515
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm: Caecum,23331,387,0.83 [0.63-1.11],0.2095870646753507
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23215,88,1.22 [0.68-2.19],0.4970160680726939
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm: Descending colon,23323,257,0.53 [0.38-0.75],0.0003573916560353
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm: Rectum,23279,408,0.76 [0.58-1.00],0.0527257215160652
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23210,687,0.76 [0.62-0.94],0.0113034787512812
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23309,545,0.68 [0.54-0.87],0.0016731744548435
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Carcinoma in situ of breast,9138,49,0.69 [0.31-1.56],0.3749122249431442
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",9182,66,0.75 [0.37-1.52],0.4325573004668597
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",16661,72,2.16 [1.14-4.12],0.0185462342213569
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",16689,100,0.58 [0.33-1.02],0.060801853389848
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23308,126,0.87 [0.53-1.43],0.5818131357601362
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Haemangioma, any site",23309,123,0.84 [0.51-1.39],0.4952237324026715
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Leiomyoma of uterus,11892,170,0.80 [0.52-1.24],0.3202400301113495
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Lung cancer and mesothelioma,14775,484,0.57 [0.44-0.73],1.485721475907433e-05
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Lymphoid leukaemia,16663,74,1.59 [0.83-3.01],0.1587585652552107
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",16817,228,1.15 [0.79-1.66],0.4717031822370062
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",16913,324,0.92 [0.68-1.25],0.604888596879392
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",9263,106,1.01 [0.58-1.75],0.984071148394878
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",16696,107,1.34 [0.79-2.27],0.2802493774428305
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",16735,146,0.94 [0.59-1.49],0.7970334529759598
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",16713,124,0.94 [0.57-1.55],0.8125975194843041
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",9245,88,2.18 [1.19-4.00],0.0117151428793694
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",16718,129,1.22 [0.75-1.99],0.4242955582595803
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",8412,980,1.02 [0.86-1.22],0.8201389576883702
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",16726,137,1.03 [0.64-1.67],0.8873494249840711
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",16681,92,1.10 [0.62-1.95],0.7558432449089503
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,16735,146,1.07 [0.67-1.70],0.7752418927255833
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Melanocytic naevi,23220,185,0.83 [0.55-1.25],0.3792636165815111
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Melanocytic naevi of trunk,23339,77,0.73 [0.39-1.38],0.3346292726821726
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Melanoma in situ,16642,112,0.84 [0.49-1.44],0.5261821890561402
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",16711,122,0.62 [0.37-1.03],0.0656614279572037
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",16791,202,0.77 [0.52-1.14],0.1968126066263227
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",16918,329,0.53 [0.39-0.73],6.546946993570528e-05
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",16718,129,0.89 [0.54-1.46],0.6495465215242171
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Other benign neoplasms of skin,23192,163,0.77 [0.50-1.19],0.2371554665929926
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",18101,1512,0.97 [0.84-1.12],0.6878889259855152
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",18187,1598,0.99 [0.86-1.14],0.8895685726946119
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23056,399,0.77 [0.58-1.02],0.0660401532450487
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,21018,165,4.81 [3.15-7.34],3.298291839931932e-13
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,22729,72,1.32 [0.69-2.53],0.3978086612529351
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,22596,3544,1.15 [1.04-1.26],0.0040878515629659
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,21625,73,1.31 [0.69-2.50],0.4108934729391469
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,22886,66,0.52 [0.26-1.03],0.0592703055445201
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22849,1996,1.19 [1.05-1.35],0.0056251998064158
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22847,1994,1.20 [1.06-1.35],0.0048729326497359
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,20970,117,1.26 [0.75-2.10],0.3847569118841546
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23002,1450,1.22 [1.06-1.41],0.0065923127151649
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,22935,115,1.32 [0.79-2.21],0.2866597763839008
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,22732,75,0.82 [0.43-1.55],0.5449831233425709
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,22733,76,1.38 [0.73-2.60],0.3222507108777177
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23183,363,1.14 [0.85-1.52],0.3819825804983138
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23234,40,1.15 [0.48-2.77],0.7592063090798592
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23118,298,1.15 [0.83-1.58],0.3993957520174752
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,21690,138,0.91 [0.57-1.47],0.7111281183868141
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,15607,418,1.21 [0.92-1.60],0.1674106344697286
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,21843,103,0.45 [0.25-0.78],0.0049112332913746
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,21856,116,0.48 [0.34-0.70],0.0001041891232528
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,15262,73,0.52 [0.27-1.02],0.0575671673583232
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,21703,65,0.99 [0.50-1.97],0.9829103747384622
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,20906,319,0.74 [0.54-1.02],0.0622583279433827
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",22561,961,1.24 [1.03-1.48],0.0199438928208115
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,22086,486,1.21 [0.93-1.56],0.1492739924057819
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,21818,218,0.85 [0.58-1.24],0.4008977702758142
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23078,1440,0.91 [0.79-1.06],0.2271219811915667
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,19656,1395,0.86 [0.74-1.00],0.057846972394133
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",15283,94,0.94 [0.53-1.69],0.8438822676633714
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",21044,102,0.88 [0.51-1.55],0.6677216027903277
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,15560,371,1.06 [0.79-1.42],0.7051204766717657
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,15246,57,0.82 [0.38-1.74],0.6001996244149248
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,19848,4659,0.83 [0.76-0.90],6.064786574337675e-06
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,15456,267,0.78 [0.55-1.10],0.160429466997767
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,15907,718,0.89 [0.72-1.10],0.2729645098396658
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23304,372,1.39 [1.05-1.85],0.0225976704856633
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23094,162,2.65 [1.74-4.04],5.697679828088911e-06
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,15344,155,0.93 [0.59-1.46],0.7497956812219133
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",15271,82,1.94 [1.04-3.59],0.0362699524767276
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22717,1775,1.16 [1.01-1.32],0.0313875291720333
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,15578,389,1.50 [1.14-1.99],0.0043941968499007
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,15619,430,1.78 [1.37-2.33],2.008532615867361e-05
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",16062,873,0.91 [0.75-1.10],0.3059733085470948
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,15369,180,1.25 [0.82-1.90],0.3027878128297643
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23084,152,2.74 [1.78-4.23],5.290119863232558e-06
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,16091,902,0.88 [0.73-1.06],0.1836362109959734
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,15851,662,0.66 [0.53-0.82],0.0001769639110641
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,20665,78,2.04 [1.10-3.78],0.0239745408005814
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,21704,6515,0.89 [0.83-0.96],0.0015708678438716
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,21003,61,1.36 [0.67-2.79],0.3952358440311027
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,20992,50,0.82 [0.37-1.84],0.628587015982408
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23179,1928,0.88 [0.77-0.99],0.0387200690777284
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23177,1926,0.87 [0.77-0.99],0.0322621611830341
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,21008,66,1.23 [0.62-2.44],0.5615665124737443
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23010,1146,0.82 [0.70-0.97],0.0211093366400992
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",17449,2260,1.02 [0.90-1.14],0.7918688942812923
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23350,316,3.15 [2.35-4.22],1.772454123947811e-14
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,21734,134,1.45 [0.90-2.33],0.1288315650536853
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,21984,120,0.92 [0.55-1.54],0.7578580301127665
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,22030,166,0.92 [0.60-1.42],0.7188283509063055
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",15390,201,1.00 [0.67-1.51],0.9840392065274004
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,20539,186,2.50 [1.67-3.73],7.424461663249688e-06
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2505,102,2.01 [1.22-3.32],0.0065127718771122
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2673,312,1.67 [1.24-2.23],0.0005944555607647
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,20440,87,2.10 [1.15-3.82],0.0151462516116362
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2476,76,7.60 [4.31-13.40],2.3143210669026817e-12
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,22509,2156,1.03 [0.91-1.16],0.6783857325639739
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,22233,633,0.96 [0.77-1.20],0.7167542990763818
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,21041,454,1.23 [0.95-1.60],0.1137578664288693
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,16319,1130,1.22 [1.04-1.45],0.0178620927668623
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23228,306,1.49 [1.09-2.04],0.0135138996940798
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),21848,266,0.86 [0.61-1.20],0.3747339623362199
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Angina pectoris,20175,1591,0.87 [0.76-1.00],0.0551770359316212
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Aortic aneurysm,21955,373,0.84 [0.63-1.12],0.2385503214631845
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,21672,90,1.22 [0.68-2.18],0.5083703637602369
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",21874,292,1.06 [0.77-1.46],0.7261869650617037
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,11826,2868,0.91 [0.82-1.02],0.0994620214696989
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,AV-block,17739,680,0.93 [0.75-1.15],0.4967350891591868
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23280,582,1.23 [0.98-1.54],0.0744832544645205
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Cardiac arrest,9224,266,1.13 [0.79-1.62],0.4984312445178507
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Cardiomyopathy,17259,200,0.83 [0.56-1.24],0.3631846088258571
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",17165,106,1.06 [0.62-1.83],0.8214412166274574
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23361,80,0.76 [0.41-1.40],0.3711226398832112
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Conduction disorders,18626,1567,0.99 [0.86-1.14],0.8542142176661134
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,21342,2782,0.91 [0.82-1.01],0.0646329094085643
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,18744,8975,0.90 [0.85-0.96],0.0010961785623274
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,DVT of lower extremities,21771,336,1.46 [1.08-1.98],0.0128749166383879
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Endocarditis,17162,103,0.81 [0.46-1.42],0.463826114592062
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23070,1685,1.01 [0.88-1.15],0.9288669205632212
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Hypertension,19994,7985,0.89 [0.83-0.94],0.0002045680668766
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Hypertension, essential",20014,8005,0.90 [0.84-0.96],0.0007307134855731
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Hypertension, portal",23191,96,1.36 [0.78-2.36],0.2768518648310741
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",12273,264,0.85 [0.61-1.18],0.3392437440429241
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,12219,210,9.18 [6.33-13.31],1.3901348713331708e-31
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Hypotension,23181,1661,1.06 [0.93-1.22],0.3913174367280677
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,22056,151,0.97 [0.61-1.53],0.8826957087393338
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",21518,2934,0.89 [0.80-0.99],0.0280535338171289
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",22846,812,0.99 [0.82-1.21],0.941989790575475
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Left bundle-branch block,17589,530,1.07 [0.83-1.36],0.6111241224271431
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,22662,1077,1.05 [0.89-1.24],0.5672163550471885
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",19513,929,1.09 [0.91-1.31],0.3502575680802114
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23236,190,1.04 [0.70-1.56],0.8298583120878982
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23321,415,1.19 [0.90-1.55],0.2186138419724785
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Oesophageal varices,21503,68,1.69 [0.88-3.25],0.1177726524871219
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other aneurysm,21686,104,0.79 [0.46-1.36],0.3942160848868337
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other arrhythmias,17664,605,1.11 [0.88-1.39],0.3842919362714242
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,21719,137,1.09 [0.68-1.75],0.7196446076608234
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,21919,337,0.97 [0.72-1.31],0.8335554892542756
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,17286,227,0.74 [0.51-1.08],0.116924380178981
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other disorders of veins,21557,122,0.92 [0.56-1.50],0.7368961470599626
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,21481,46,0.67 [0.30-1.50],0.3289833268240976
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,21286,92,0.73 [0.41-1.31],0.2972969109682173
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,21618,183,0.92 [0.62-1.38],0.6982674469473884
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,18545,1486,0.92 [0.80-1.07],0.2824335734109124
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,21583,63,3.06 [1.57-5.98],0.0010619223539595
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,22322,740,1.06 [0.86-1.30],0.5761518824044616
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,22584,532,0.86 [0.68-1.09],0.2129768154777422
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",22181,987,1.03 [0.87-1.23],0.717017774453743
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,9376,418,0.77 [0.58-1.02],0.068315625473572
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Peripheral artery disease,22145,599,1.07 [0.86-1.34],0.5420229942504551
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),21861,426,1.44 [1.10-1.88],0.0073719175797219
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Pulmonary embolism,22660,608,1.03 [0.82-1.28],0.8261735231601899
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23263,982,0.98 [0.82-1.17],0.8209507860799029
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Right bundle-branch block,17578,519,1.05 [0.82-1.34],0.721113451989984
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Secondary right heart disease,22577,525,0.84 [0.66-1.07],0.1628876342410554
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,21464,270,1.06 [0.76-1.48],0.7316673021161708
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",22830,925,0.98 [0.82-1.18],0.8704304742166639
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",22815,966,1.03 [0.86-1.23],0.7461871736767005
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,22023,64,1.48 [0.74-2.98],0.2651070362100842
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,21689,107,0.98 [0.57-1.68],0.9413959020950252
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Transient ischemic attack,22361,327,1.12 [0.83-1.52],0.4628269575534247
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,21922,337,0.88 [0.65-1.19],0.3970038912622415
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Varicose veins,21960,525,1.13 [0.89-1.44],0.3256307858901507
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,21600,123,1.17 [0.71-1.94],0.5363831867079327
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23085,956,1.25 [1.05-1.50],0.0140034955303129
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23283,338,0.38 [0.28-0.51],2.1311672565006752e-10
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",19954,1393,0.83 [0.71-0.96],0.013551077466878
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,Any mental disorder,22824,4263,0.86 [0.79-0.94],0.0008785380238852
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23254,397,0.41 [0.31-0.54],1.8571449983025844e-10
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",20029,1468,0.88 [0.76-1.02],0.0940386404289778
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",18647,86,0.66 [0.36-1.22],0.1854573146524077
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,Smoking dependency,22843,1190,0.75 [0.64-0.88],0.0005876215962091
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",20026,1465,0.71 [0.61-0.82],3.5949630012722388e-06
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,Vascular dementia,22456,233,1.18 [0.82-1.70],0.3742329754625794
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Alzheimer disease,23363,597,1.12 [0.89-1.41],0.3174324943319437
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",14305,112,2.16 [1.28-3.64],0.0038743266646589
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Bell's palsy,21496,84,0.96 [0.53-1.76],0.9064861105197008
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,21911,499,1.11 [0.86-1.42],0.4219017010917505
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Cerebral cysts,22906,252,1.25 [0.88-1.77],0.2119942572911805
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23288,417,0.80 [0.61-1.05],0.1076207441642997
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,22499,75,0.75 [0.40-1.43],0.3878311734566673
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23344,68,1.41 [0.73-2.73],0.3078088900271434
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",22742,88,0.87 [0.48-1.58],0.6557613194883861
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Epilepsy,21836,307,0.83 [0.60-1.14],0.2403674288379216
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22894,1365,0.94 [0.81-1.09],0.4110185195737719
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23309,931,0.95 [0.80-1.14],0.6150874811874558
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Falls/tendency to fall,22697,3480,1.00 [0.91-1.10],0.9479956387352956
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Generalized epilepsy,22978,54,1.30 [0.61-2.78],0.4947060341153813
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Hemiplegia,23212,341,0.90 [0.67-1.21],0.4758134296039106
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Hydrocephalus,22730,76,0.91 [0.48-1.72],0.7680708580046456
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23350,75,1.03 [0.54-1.97],0.9228067225788336
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,21480,68,1.07 [0.54-2.13],0.836509124262133
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,21484,72,0.60 [0.32-1.14],0.1204556443524493
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Memory loss,22201,143,1.43 [0.90-2.27],0.1321236995131069
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Migraine,21810,281,0.98 [0.70-1.37],0.9020681596257802
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23315,258,1.02 [0.72-1.45],0.8964928750682725
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Motor neuron disease,14393,176,0.80 [0.52-1.23],0.3164751536099218
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23229,62,0.84 [0.41-1.70],0.6210549288230899
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22651,1239,1.09 [0.93-1.27],0.3025652150008782
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Neurological diseases,21858,4402,1.02 [0.94-1.11],0.6548301153460139
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,22754,330,0.91 [0.67-1.23],0.5382956101143588
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",21842,430,1.14 [0.87-1.49],0.3340789548011185
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23282,354,1.79 [1.34-2.39],8.435040656180898e-05
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,17475,990,1.03 [0.86-1.24],0.7199101884043558
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,22740,86,1.16 [0.64-2.10],0.6187602975058983
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other disorders of nervous system,22818,164,1.55 [1.02-2.38],0.0420068770196996
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,22615,237,1.05 [0.73-1.51],0.800387139426016
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other facial nerve disorders,21508,96,0.98 [0.56-1.73],0.9523485389118924
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other headache syndromes,21582,53,0.57 [0.26-1.23],0.1494940087806436
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other neurological diseases,23246,592,1.10 [0.88-1.39],0.3927377056250279
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other sleep disorders,22051,522,0.91 [0.71-1.16],0.43158464948057
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Parkinson's disease,23330,690,0.91 [0.73-1.12],0.3592132570795832
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,22699,45,1.32 [0.57-3.05],0.5141555760644041
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Restless leg syndrome,23363,109,1.17 [0.68-1.99],0.5719594374808878
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Sleep apnoea,23130,445,0.87 [0.67-1.13],0.3075014324442887
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Small fibre neuropathy,22990,62,1.06 [0.52-2.15],0.8786284868813472
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23351,205,0.79 [0.54-1.17],0.2368949305453021
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,21483,71,0.72 [0.37-1.39],0.3245499850856136
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23363,603,1.13 [0.90-1.42],0.3060357072543506
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),22394,227,1.20 [0.83-1.73],0.3430188380691704
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,22711,155,0.75 [0.48-1.18],0.2186619684157193
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,22901,576,0.94 [0.75-1.19],0.6319085135380622
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23107,270,1.69 [1.22-2.35],0.0016143416193713
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,22114,69,0.37 [0.19-0.71],0.0032468739607998
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22084,39,1.06 [0.43-2.59],0.8972808325712655
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23238,72,0.84 [0.43-1.61],0.5932875740617707
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23044,230,1.19 [0.82-1.72],0.354662079160065
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2480,77,6.22 [3.55-10.90],1.6261765546820834e-10
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,3057,116,2.07 [1.30-3.29],0.0020471937797386
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,22666,110,0.84 [0.49-1.43],0.518429135515506
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23062,1439,1.15 [0.99-1.33],0.0693358676638031
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",22941,896,0.88 [0.73-1.06],0.1726707798044454
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22353,308,0.91 [0.66-1.25],0.5443719277991681
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23289,964,0.98 [0.81-1.17],0.7954420523014384
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23357,83,1.64 [0.90-3.00],0.1092601078336332
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23214,889,0.92 [0.76-1.11],0.3940630159104166
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23320,506,1.03 [0.81-1.32],0.7972497638574794
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23241,227,1.06 [0.73-1.53],0.7592571297749351
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,22145,100,0.88 [0.51-1.54],0.6613164692302994
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,22150,105,0.95 [0.55-1.63],0.8446267241818722
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,22124,79,0.74 [0.39-1.39],0.3448421104538897
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23224,1023,1.09 [0.91-1.29],0.3438758028375607
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,22467,266,1.41 [1.01-1.98],0.0464525305423692
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,22395,70,0.91 [0.47-1.78],0.782192719807355
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,22937,123,0.80 [0.48-1.32],0.3795583565628631
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23212,398,1.14 [0.86-1.51],0.3487286319848265
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,22548,223,0.90 [0.62-1.32],0.5978305581642958
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23156,142,0.93 [0.58-1.49],0.7698568611231857
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,22886,685,1.07 [0.87-1.32],0.5239483088232912
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,22715,159,0.89 [0.57-1.38],0.5992938124410478
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,20880,3282,1.04 [0.94-1.15],0.4445404681667565
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23166,352,1.15 [0.86-1.55],0.3511042899857683
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23348,191,1.13 [0.76-1.69],0.5512151784325016
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,22593,548,0.84 [0.66-1.06],0.1370375878427076
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,22904,90,0.89 [0.50-1.59],0.6935462446605117
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23348,74,1.80 [0.95-3.40],0.0723718724999349
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,22175,130,0.91 [0.56-1.48],0.6941183016817014
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22222,177,0.72 [0.47-1.09],0.1245296331794508
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,21789,166,0.86 [0.56-1.34],0.5102288230482519
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,22389,64,2.10 [1.06-4.18],0.034420450397501
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",21698,75,0.51 [0.27-0.98],0.0423997837898782
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,22317,116,1.10 [0.65-1.84],0.7311450894775756
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",22498,297,1.36 [0.99-1.88],0.0594612512914251
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,22207,162,0.95 [0.62-1.48],0.8332155085350846
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,21718,95,1.02 [0.58-1.82],0.934167807161336
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,21757,134,0.91 [0.56-1.47],0.689622156348756
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,20366,2768,0.94 [0.85-1.05],0.2875736068496136
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,22140,95,0.70 [0.39-1.23],0.213717617633672
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23067,511,0.87 [0.68-1.12],0.285399966553071
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,22637,81,0.85 [0.46-1.58],0.6180934614280669
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),22765,209,1.24 [0.84-1.82],0.2746537524985568
RGMA,Repulsive guidance molecule A,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23139,114,1.49 [0.88-2.52],0.1331064373502214
RGMA,Repulsive guidance molecule A,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23315,139,1.18 [0.74-1.88],0.4858753310875563
RGMA,Repulsive guidance molecule A,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23224,120,1.13 [0.68-1.87],0.6442941483840102
RGMA,Repulsive guidance molecule A,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23090,65,1.48 [0.74-2.95],0.2663644183887532
RGMA,Repulsive guidance molecule A,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,23095,70,1.17 [0.60-2.27],0.6504575472315313
RGMA,Repulsive guidance molecule A,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23257,1258,0.97 [0.83-1.14],0.7149745264455782
RGMA,Repulsive guidance molecule A,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,22951,952,0.95 [0.79-1.14],0.5695839561840899
RGMA,Repulsive guidance molecule A,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,22154,155,1.30 [0.84-2.03],0.2435120915865748
RGMA,Repulsive guidance molecule A,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,22089,90,0.85 [0.47-1.52],0.5765904758420652
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Acute pharyngitis,23167,66,0.87 [0.44-1.73],0.6936404825905798
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23290,189,0.94 [0.63-1.40],0.7560503154705244
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23165,64,1.52 [0.77-3.00],0.2312865618153368
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,All influenza,20645,159,1.45 [0.93-2.25],0.102538359277386
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),20642,156,1.44 [0.92-2.25],0.1107186604715473
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Allergic asthma (mode),14394,103,0.96 [0.55-1.69],0.898689001191112
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Allergic rhinitis,23254,240,0.78 [0.54-1.12],0.1753466041863724
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",15627,1733,0.84 [0.73-0.97],0.0136442553663016
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",16002,1711,0.84 [0.73-0.96],0.01132219130215
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),22840,182,1.24 [0.83-1.87],0.2949356480422035
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",20592,106,0.78 [0.45-1.34],0.3727481830712915
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Bronchiectasis,19586,526,0.60 [0.47-0.76],3.5348116825978464e-05
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",19133,73,0.98 [0.51-1.89],0.9540132512690168
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,22223,3163,0.80 [0.72-0.88],6.350845890467449e-06
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",22128,72,0.94 [0.48-1.81],0.8457577821289732
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Chronic sinusitis,22190,134,0.74 [0.46-1.19],0.2147756002963013
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23067,1652,0.71 [0.62-0.82],1.0337504714787366e-06
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Deviated nasal septum,22135,79,0.42 [0.22-0.78],0.0059058223464993
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,21192,6175,0.83 [0.77-0.89],3.6440341418815233e-07
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22397,341,0.70 [0.52-0.94],0.0177820828216994
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Early onset COPD,21524,109,0.66 [0.38-1.12],0.121369081853053
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Emphysema,19495,435,0.81 [0.62-1.06],0.1258796540431083
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22036,456,0.72 [0.55-0.93],0.0130974502465415
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23103,2617,0.90 [0.80-1.00],0.0489196262595194
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Interstitial lung disease,22080,500,0.73 [0.57-0.93],0.0120871094418545
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Later onset COPD,22835,1543,0.71 [0.62-0.82],2.8087444432114807e-06
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23346,500,1.00 [0.78-1.28],0.9874002753611638
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Nasal polyp,22153,97,0.85 [0.49-1.50],0.5814221685437606
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23078,1316,1.05 [0.90-1.22],0.5418680663109616
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Other diseases of pleura,23068,2714,0.87 [0.78-0.97],0.012614253124075
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,22815,759,0.76 [0.62-0.93],0.0072391895127805
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Other pleural conditions,20422,68,1.30 [0.66-2.54],0.4496162613868926
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23240,597,0.81 [0.65-1.02],0.0749097806516424
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23231,1730,0.86 [0.75-0.98],0.0259155486034943
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Pleural effusion,21738,1384,0.94 [0.81-1.09],0.4101956790999738
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Pleural plaque,20608,254,0.82 [0.58-1.16],0.2701772686239205
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",22812,2326,0.87 [0.77-0.98],0.0180471279253962
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23236,390,1.17 [0.89-1.55],0.2647833798341623
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Pneumothorax,20524,170,0.68 [0.44-1.05],0.0854677514317914
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Pollen allergy,23351,204,0.79 [0.53-1.17],0.2346642905396816
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Pulmonary oedema,22735,92,1.40 [0.79-2.47],0.2453387816304961
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Respiratory insufficiency,14361,70,0.31 [0.16-0.59],0.0004393574532825
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23054,1292,1.05 [0.90-1.23],0.5285126323701461
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22298,242,0.77 [0.54-1.11],0.1592530242663596
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Viral pneumonia,20790,304,1.26 [0.92-1.74],0.1491395367728178
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",22849,243,1.36 [0.96-1.93],0.0862757184889967
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,7434,121,0.74 [0.44-1.25],0.26723571740606
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,14800,62,1.24 [0.61-2.51],0.5536461398097933
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Acute appendicitis,23245,130,1.36 [0.84-2.20],0.2173318387941047
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Acute gastritis,16230,104,1.78 [1.04-3.06],0.0356020542276637
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Acute pancreatitis,21297,199,1.21 [0.82-1.79],0.3341263878329363
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Acute peritonitis,22861,113,1.79 [1.07-3.00],0.0258875483482637
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Alcoholic liver disease,22377,65,0.59 [0.30-1.17],0.1288945417380299
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Barrett oesophagus,16639,513,1.15 [0.90-1.48],0.2528153399205335
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",21241,143,1.44 [0.91-2.27],0.1220978701617646
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",22937,143,1.44 [0.91-2.27],0.1159337084454372
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Cholecystitis,21322,224,1.24 [0.86-1.79],0.2589647999818072
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Cholelithiasis,22157,1059,1.10 [0.93-1.31],0.2519957209871051
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Chronic gastritis,16476,350,1.18 [0.87-1.58],0.2878993332034215
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Chronic pancreatitis,21153,55,0.84 [0.40-1.78],0.6513616932650093
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23222,127,1.36 [0.84-2.19],0.211410848560815
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Coeliac disease,21601,128,1.04 [0.63-1.72],0.868890764287829
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Collagenous colitis,21596,104,1.54 [0.89-2.67],0.1240049025850146
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23245,159,0.78 [0.50-1.21],0.2680341215851146
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Constipation,23076,2153,1.04 [0.92-1.17],0.5659805915012419
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Crohn disease,21582,90,1.55 [0.87-2.77],0.1398642168929489
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23009,69,1.10 [0.56-2.14],0.7860257923221878
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Crohn's disease NAS,21574,82,1.73 [0.94-3.19],0.0764798152101599
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Dental caries,22740,188,1.80 [1.21-2.68],0.0037887642719069
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,20184,2597,0.99 [0.89-1.11],0.9256829757120568
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of appendix,23276,161,1.29 [0.83-1.99],0.2562610886803873
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of liver,23241,929,0.93 [0.77-1.11],0.4127619832179386
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",20779,4653,0.99 [0.91-1.08],0.860515113168451
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23026,474,1.30 [1.01-1.67],0.0436317160722132
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23269,521,0.98 [0.77-1.25],0.8852783632392661
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22646,94,1.47 [0.83-2.60],0.1850249889834595
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of salivary glands,22516,59,0.95 [0.46-1.96],0.8875489305703994
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23019,1546,1.02 [0.88-1.17],0.8189020464301338
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of tongue,22537,97,1.81 [1.03-3.17],0.0375520274236243
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22633,1535,1.14 [0.99-1.31],0.0679849646636086
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,18561,3823,0.89 [0.81-0.97],0.0092680889808732
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Duodenal ulcer,16378,252,0.90 [0.64-1.28],0.5710491853451136
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23268,205,0.84 [0.57-1.23],0.3609985803399834
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23324,28,1.46 [0.51-4.17],0.4803353571099849
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,22461,149,1.33 [0.85-2.07],0.2123790034283369
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,14846,108,1.30 [0.76-2.21],0.3342014485939182
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Functional dyspepsia,16697,571,0.89 [0.70-1.12],0.3249465719133487
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Gastric ulcer,16555,429,1.00 [0.77-1.31],0.9843850425729797
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,18821,2695,0.95 [0.85-1.06],0.331365488998139
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,16783,657,0.91 [0.73-1.13],0.3953037895866618
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,16863,8306,0.99 [0.93-1.05],0.79378149402848
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,GI-bleeding,22757,1284,1.00 [0.86-1.17],0.9975249859071914
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,22597,45,0.53 [0.23-1.22],0.1347614604630417
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,15740,1193,0.92 [0.78-1.08],0.3086225825028744
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",22380,68,1.54 [0.79-2.98],0.2022897438741746
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Hernia,21282,3695,0.94 [0.86-1.03],0.18418236270941
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Impacted teeth,23328,26,1.01 [0.34-3.01],0.992541140849688
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Impaction of intestines,14817,79,0.92 [0.49-1.74],0.7989654504119127
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Inguinal hernia,18702,1115,0.84 [0.71-0.99],0.0358214279079027
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",17713,126,0.68 [0.41-1.12],0.1303322486704695
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,14856,118,1.41 [0.84-2.36],0.1956096125086721
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Intestinal malabsorption,21620,147,1.04 [0.66-1.66],0.855127039542241
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,15259,521,1.09 [0.85-1.40],0.4821113527287303
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23331,342,0.93 [0.69-1.24],0.6129268457861079
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22287,795,1.09 [0.89-1.32],0.3968977170514693
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22597,1105,1.06 [0.90-1.25],0.4880015504217186
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Oesophageal obstruction,16349,223,0.72 [0.49-1.05],0.0854466221640378
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Oesophagitis,16836,710,0.94 [0.76-1.16],0.5631265723562255
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23307,136,0.99 [0.62-1.60],0.978920416557899
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,17674,87,1.31 [0.72-2.37],0.3709847422349143
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,16127,1389,0.82 [0.71-0.96],0.0122199357523058
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,21457,359,1.09 [0.82-1.47],0.5481958836104784
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,21245,147,1.43 [0.91-2.26],0.120660401461887
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of intestine,16688,1950,0.95 [0.84-1.08],0.422727817013844
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of intestines,21020,6282,0.97 [0.90-1.04],0.4166656442991978
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22495,210,1.04 [0.71-1.53],0.8309097145402333
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of liver,23081,769,1.01 [0.82-1.23],0.955414877264961
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,16903,777,1.02 [0.84-1.25],0.8307295450722475
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of pancreas,21316,218,1.61 [1.11-2.33],0.0127340769079633
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23190,442,0.87 [0.67-1.14],0.3198583510537836
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,17236,1110,1.18 [1.00-1.39],0.0553020948759479
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22774,1301,0.99 [0.85-1.16],0.914621070136128
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22733,181,1.21 [0.80-1.82],0.3702509421298998
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,16938,2200,1.01 [0.90-1.14],0.8209066192971118
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),18324,2198,1.00 [0.88-1.12],0.9413081985063436
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,22426,114,1.34 [0.80-2.24],0.262817084072875
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22467,975,1.09 [0.91-1.30],0.3485925749559555
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",15190,452,1.05 [0.80-1.37],0.7254091935661205
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23320,32,1.77 [0.66-4.70],0.2548282701834126
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,15362,624,0.97 [0.77-1.21],0.7798761837859836
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",21633,160,1.41 [0.91-2.18],0.1261509558210842
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23350,53,0.81 [0.38-1.75],0.5982785477758037
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22545,104,1.01 [0.58-1.75],0.9753368330224084
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Toxic colitis,21573,81,1.05 [0.57-1.96],0.871301694589494
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,16473,347,0.96 [0.71-1.30],0.7990151383501372
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Ulcerative colitis,21661,169,1.11 [0.72-1.71],0.6300222420118496
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",21627,135,1.13 [0.70-1.82],0.6165575822764585
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Umbilical hernia,17845,258,1.11 [0.79-1.57],0.5416448521083358
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,14985,247,1.06 [0.74-1.52],0.7476472484933131
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Ventral hernia,17879,292,0.73 [0.52-1.01],0.0544510691031435
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Volvulus,14832,94,0.51 [0.28-0.91],0.0225626849657718
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23256,433,1.20 [0.92-1.56],0.1880898598800277
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,22992,67,0.66 [0.33-1.30],0.2269256959985696
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,20773,170,1.33 [0.87-2.05],0.1937353427687339
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22722,840,1.02 [0.84-1.23],0.8589495819657249
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22030,148,0.89 [0.57-1.41],0.6317812568621732
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,21246,643,1.08 [0.87-1.35],0.4681776269353114
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23016,322,0.77 [0.56-1.04],0.0895560262163829
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23260,566,0.95 [0.75-1.19],0.6382041354960072
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,22742,48,0.74 [0.33-1.65],0.4579966249810734
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,21748,3779,1.09 [0.99-1.19],0.0645748310731413
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,22928,443,1.02 [0.78-1.32],0.9112852938842542
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,22792,307,0.98 [0.72-1.35],0.9221470550310958
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,22974,1092,1.01 [0.85-1.19],0.9157966969669534
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23342,62,1.00 [0.49-2.04],0.9967344520949754
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,20661,58,2.56 [1.25-5.25],0.0102346869050496
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22549,64,1.63 [0.83-3.20],0.158355402161177
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23002,308,0.78 [0.57-1.08],0.1327876758213616
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,21217,614,1.16 [0.92-1.45],0.2037615595508839
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,20695,92,1.03 [0.58-1.85],0.910140230269933
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23274,97,1.89 [1.09-3.27],0.0237329227279873
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,22122,240,0.96 [0.68-1.37],0.8385110427128318
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23153,228,0.95 [0.66-1.37],0.7935614472434741
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,22790,96,1.61 [0.92-2.81],0.0932339932099432
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,20682,79,1.45 [0.77-2.71],0.2457720834107807
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22742,2139,1.11 [0.99-1.26],0.0756647572978579
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",21263,660,1.20 [0.96-1.49],0.1020713093963722
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,20699,96,1.01 [0.57-1.79],0.9635578437090622
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23269,344,0.92 [0.68-1.24],0.5765425393483417
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,22770,76,0.95 [0.50-1.80],0.883811890228623
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23205,280,0.91 [0.66-1.27],0.5904725182542652
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23287,464,1.28 [0.99-1.65],0.0643199054168116
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,20730,127,1.28 [0.78-2.11],0.3264399432662315
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,20943,340,1.06 [0.78-1.43],0.712645043096883
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23276,453,1.24 [0.95-1.61],0.1104491423180506
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",20946,343,1.14 [0.84-1.53],0.3988356422787641
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23336,159,1.58 [1.03-2.44],0.0379189667616531
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,19461,83,1.47 [0.81-2.69],0.205779821830364
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,20575,6511,0.96 [0.90-1.03],0.2748042597785275
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,19153,5089,0.95 [0.88-1.03],0.1978935131972095
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,19432,54,0.81 [0.38-1.73],0.58871626662396
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,19370,147,1.55 [0.98-2.44],0.059479484287788
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,19416,193,1.46 [0.98-2.17],0.0648084580206102
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23097,66,1.82 [0.93-3.57],0.0798066161069949
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",19375,152,0.86 [0.54-1.36],0.5118307469242833
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,15565,1501,0.95 [0.82-1.10],0.4971197009040535
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23151,250,1.02 [0.72-1.45],0.912815908598251
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,19818,595,0.90 [0.72-1.14],0.3967216011192116
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,18886,8112,0.93 [0.87-0.99],0.021853455457712
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,20787,121,0.68 [0.41-1.14],0.1436422135947496
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,19562,184,0.91 [0.60-1.37],0.6422189768849126
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,19892,514,0.86 [0.67-1.10],0.2413606600816582
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22409,3186,0.99 [0.90-1.10],0.8824125276894808
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,19692,314,0.82 [0.60-1.12],0.214539044380511
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,19529,151,0.77 [0.49-1.22],0.270430498732417
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,19495,117,0.73 [0.44-1.24],0.2485726031272284
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,22597,104,1.07 [0.61-1.86],0.8226226411918008
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,16097,2033,0.92 [0.81-1.04],0.1927591725656608
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,14869,805,1.13 [0.94-1.36],0.1907727979766216
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23264,798,1.12 [0.92-1.35],0.2551210350010457
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,14142,78,0.74 [0.39-1.41],0.3616328666232205
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),14369,305,1.18 [0.85-1.64],0.3164763837839227
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,19647,269,0.77 [0.55-1.08],0.1326714619915928
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,14548,484,1.06 [0.82-1.36],0.6720712178460235
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,19305,82,0.81 [0.44-1.52],0.519004735535467
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,19914,691,1.02 [0.83-1.26],0.8525847010827446
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,19545,322,1.20 [0.88-1.63],0.258222777584959
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,14517,453,1.08 [0.83-1.41],0.5552124359284722
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,19451,73,1.72 [0.90-3.29],0.1018939636415703
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",19439,61,1.12 [0.55-2.29],0.7484617355454523
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,20753,87,1.43 [0.80-2.55],0.2268071856443565
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,22925,2259,0.92 [0.81-1.03],0.1541200109860207
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22248,1582,0.92 [0.79-1.06],0.2334897240296707
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23191,552,1.10 [0.87-1.39],0.4286825227284971
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,17240,3176,0.90 [0.81-0.99],0.0327852656325625
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,14107,43,0.50 [0.21-1.19],0.118332322166821
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,19484,106,1.44 [0.84-2.46],0.1864024308732609
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,14135,71,2.49 [1.32-4.70],0.0047850483046358
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),14200,136,1.10 [0.68-1.80],0.6887146921138001
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,20913,247,0.86 [0.60-1.22],0.3922882110747486
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,21184,518,0.99 [0.77-1.28],0.9643542613013087
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23339,114,1.41 [0.84-2.37],0.1966554520108302
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",21231,2008,1.05 [0.93-1.19],0.4485135792335603
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,19456,78,1.33 [0.71-2.50],0.3770690347740688
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),14221,157,1.28 [0.81-2.02],0.2842267390981298
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,20030,807,1.01 [0.83-1.23],0.9044120350830676
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,16272,2208,1.02 [0.90-1.15],0.7846740216322651
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,22624,131,1.21 [0.74-1.97],0.4522339265617583
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23351,64,0.61 [0.30-1.21],0.1568888683619344
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,19457,79,0.87 [0.46-1.62],0.6532875806865133
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",20752,1374,0.95 [0.82-1.11],0.5449930902830883
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,19487,109,1.07 [0.63-1.83],0.7918949625216893
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,16158,2094,0.85 [0.75-0.96],0.0088397919601006
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,20785,119,0.68 [0.40-1.13],0.1382340882271832
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,19416,38,0.79 [0.32-1.99],0.6223034289604813
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,19423,200,1.08 [0.73-1.59],0.7171124328369274
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20071,693,0.97 [0.79-1.20],0.802383716262082
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,22992,499,1.13 [0.88-1.46],0.339152732788578
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,19890,667,1.04 [0.84-1.29],0.6949834288246471
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23206,546,1.12 [0.88-1.42],0.3562431899574905
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23337,69,1.38 [0.71-2.68],0.3454172022854956
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,19547,169,0.89 [0.58-1.37],0.5847488488382879
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,18163,903,1.18 [0.98-1.42],0.0851376495255814
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20035,657,0.97 [0.78-1.20],0.7734805020762057
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],19660,282,0.78 [0.56-1.09],0.1416905161568801
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",14136,72,1.24 [0.64-2.41],0.5218093677770577
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,17225,3161,0.91 [0.83-1.01],0.0783836973084363
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,14914,850,0.97 [0.80-1.17],0.7414285426770735
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,22873,380,1.04 [0.78-1.39],0.7724217184221744
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23306,81,1.83 [0.99-3.38],0.053533051430474
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",20668,72,1.12 [0.59-2.13],0.7305536825323524
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,14129,65,0.58 [0.29-1.17],0.1293067432388338
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,19332,109,1.35 [0.79-2.30],0.269710445312325
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,14624,560,1.04 [0.82-1.32],0.7391590722263945
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,19719,341,0.75 [0.55-1.01],0.0580242574092354
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,19512,289,1.07 [0.77-1.48],0.6759366065183156
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,19494,271,0.87 [0.62-1.22],0.4154822754019882
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,16401,67,0.72 [0.36-1.45],0.3585729990293557
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23342,74,1.56 [0.82-2.97],0.1728122472557696
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,19941,563,0.77 [0.61-0.97],0.0262172195653931
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],22590,97,1.38 [0.78-2.46],0.2676354126724724
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22057,2679,0.95 [0.85-1.05],0.3168274226831594
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",19528,150,0.87 [0.55-1.38],0.5543608412390328
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,19947,724,1.15 [0.93-1.41],0.1906454707643258
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,21967,278,1.12 [0.80-1.56],0.5091910200181431
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,19482,259,1.05 [0.74-1.50],0.7656671346629873
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,21261,2038,0.99 [0.87-1.12],0.8193866708992215
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,20552,1329,0.98 [0.84-1.14],0.7591723847027102
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],19441,63,1.65 [0.82-3.30],0.157868036387166
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22612,119,1.25 [0.75-2.09],0.3936563635961724
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,19543,165,1.06 [0.69-1.64],0.78080908305113
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,19469,91,1.02 [0.57-1.84],0.942965492262728
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),14142,78,1.43 [0.77-2.69],0.2599040775276836
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Acute renal failure,21828,2277,1.76 [1.57-1.98],1.2466419316728677e-21
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9353,26,0.64 [0.21-1.96],0.4326284935414656
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,11871,33,0.36 [0.13-0.96],0.041314142013114
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23028,315,1.04 [0.77-1.42],0.7867937966135854
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,22821,108,0.71 [0.42-1.21],0.2076838141108205
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,21914,2363,3.48 [3.11-3.88],5.139152581448378e-108
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23128,132,10.39 [7.04-15.32],3.689408084468277e-32
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23050,410,1.36 [1.04-1.79],0.0263126251305497
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Cystitis,19455,302,1.11 [0.80-1.53],0.5266815421050909
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Dialysis,19647,96,16.72 [11.02-25.36],4.919287141451163e-40
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,10294,2171,0.96 [0.85-1.08],0.5070103307031386
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Disorders of breast,11973,135,0.74 [0.45-1.20],0.2193387473575112
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Endometriosis,9367,40,1.16 [0.47-2.86],0.7513168201022125
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,9915,588,0.63 [0.50-0.80],0.0001540796292277
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,19245,6369,1.18 [1.10-1.27],4.611145928370036e-06
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23093,97,6.67 [4.04-10.99],1.0670763334106397e-13
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Hydrocele,8241,118,0.72 [0.44-1.20],0.2135729628904979
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,19622,353,1.47 [1.09-1.98],0.0125473918422305
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,9974,1851,0.96 [0.84-1.09],0.5204127314361382
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,12037,159,0.96 [0.61-1.50],0.8501771918104872
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),8249,126,0.97 [0.60-1.59],0.9141905194227384
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,19243,90,0.93 [0.51-1.67],0.8034103494515461
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,10372,1045,0.80 [0.67-0.95],0.0120427690438456
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,8182,59,0.94 [0.46-1.91],0.8586050125409398
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,9367,40,0.89 [0.36-2.21],0.8059045884650343
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23348,89,1.36 [0.76-2.43],0.3058442475961386
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23351,85,0.84 [0.46-1.53],0.5614478643455104
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22141,2988,1.00 [0.90-1.11],0.971212136110408
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,20107,954,0.90 [0.75-1.08],0.2552795000144148
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,11889,51,1.09 [0.49-2.42],0.8241874755200479
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23276,636,1.79 [1.44-2.22],1.3815220965292798e-07
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,8276,153,1.13 [0.73-1.76],0.5804777639064385
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,8283,160,0.93 [0.60-1.43],0.7285309813406273
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,8279,156,0.93 [0.60-1.45],0.7566756616915632
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23323,84,0.72 [0.39-1.33],0.2943253505348905
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,21531,2378,1.06 [0.95-1.19],0.3127263465172749
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,11961,83,0.99 [0.53-1.85],0.9840783144502988
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9395,68,1.01 [0.50-2.03],0.980825246665024
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",9470,143,0.96 [0.59-1.56],0.8758518284711879
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9381,54,0.30 [0.14-0.65],0.0022393863709525
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9429,102,0.57 [0.33-1.02],0.0565895899990145
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,19684,415,1.55 [1.18-2.05],0.0017818745768898
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,22845,205,2.23 [1.52-3.26],3.55436171543387e-05
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,9454,127,1.52 [0.91-2.53],0.1111152840783367
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9352,25,0.80 [0.25-2.53],0.7026437019066581
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,9540,213,0.81 [0.55-1.20],0.2987815495976702
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,9421,94,0.97 [0.53-1.75],0.9109824314138733
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,9538,211,0.69 [0.47-1.03],0.0680059078453719
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,23045,49,4.19 [1.98-8.87],0.0001830616349851
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",8280,157,1.04 [0.67-1.60],0.8757887845751366
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23069,3800,2.01 [1.84-2.20],4.879637642818151e-52
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",19364,95,1.13 [0.63-2.03],0.6812510577202253
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,19732,181,2.80 [1.86-4.21],8.131001548950003e-07
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,22753,40,1.77 [0.76-4.12],0.1877036067669545
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Urethral stricture,19423,270,1.18 [0.84-1.66],0.3284693999047257
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23117,404,0.99 [0.75-1.30],0.9449759350588488
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Uterine polyps,9363,36,0.70 [0.27-1.79],0.4563316691655557
